Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 16, 2021
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
Tue, June 15, 2021
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
[ Tue, Jun 15th 2021
] - WOPRAI
Brian Cheng Initiated (ADCT) at Buy and Held Target at $46 on, Jun 15th, 2021
Brian Cheng of Cantor Fitzgerald, Initiated "ADC Therapeutics SA" (ADCT) at Buy and Held Target at $46 on, Jun 15th, 2021.
Brian has made no other calls on ADCT in the last 4 months.
There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Brian's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Brian
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Friday, May 14th, 2021
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $53 on, Monday, May 10th, 2021
